Replimune (REPL) Weakness Tied to FDA Briefing Documents, Shares -18%

July 28, 2026 7:30 AM

(Updated - July 28, 2026 7:34 AM EDT)

Replimune (NASDAQ: REPL) Weakness Tied to FDA Briefing Documents, Shares -18%More:The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found